Tuphan K Dolai Selected Research

Abnormal Hemoglobins

11/2020

Implications of Population Screening for Thalassemias and Hemoglobinopathies in Rural Areas of West Bengal, India: Report of a 10-Year Study of 287,258 Cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tuphan K Dolai Research Topics

Disease

2	Multiple Myeloma 01/2021 - 11/2020
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 11/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021
1	Fatigue 11/2020
1	Pneumonia (Pneumonitis) 11/2020
1	Thrombocytopenia (Thrombopenia) 11/2020
1	Hemoglobinopathies 11/2020
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2020
1	Lymphoma (Lymphomas) 02/2020
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2020
1	Eosinophilia 12/2014
1	Exanthema (Rash) 12/2014
1	Thymoma (Thymic Carcinoma) 03/2009
1	Pure Red-Cell Aplasia 03/2009

Drug/Important Bio-Agent (IBA)

2	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 12/2014
2	selinexorIBA 01/2021 - 11/2020
2	Bortezomib (Velcade)FDA Link 01/2021 - 11/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 11/2020
1	Proteasome InhibitorsIBA 11/2020
1	Abnormal HemoglobinsIBA 11/2020
1	Biological ProductsIBA 02/2020
1	Biosimilar PharmaceuticalsIBA 02/2020
1	Rituximab (Mabthera)FDA Link 02/2020
1	CytokinesIBA 01/2020
1	ImmunosorbentsIBA 01/2020
1	EnzymesIBA 01/2020
1	Pharmaceutical PreparationsIBA 12/2014

Therapy/Procedure

2	Therapeutics 01/2021 - 11/2020
1	Thymectomy 03/2009